U.S. private equity firm KKR and Assura have agreed on the terms of a "best and final" offer for the British healthcare real estate investor's sale, valuing it at nearly 1.7 billion pounds ($2.29 billion), the companies said on Wednesday.
The board of Assura Group (LSE:AGR) has recommended an increased £1.7 billion final takeover offer from private equity groups KKR and Stonepeak, rejecting a rival proposal from Primary Health Properties PLC (LSE:PHP, OTC:PHPRF). KKR and Stonepeak, through their Sana 'bidco' vehicle, upped their final offer to 52.1p per share in cash, including two 0.84p dividends.
KKR & Co. Inc. (NYSE:KKR ) Morgan Stanley US Financials, Payments & CRE Conference Call June 10, 2025 9:00 AM ET Company Participants Adam Smith - Partner, Co-Head of Credit & Markets Conference Call Participants Michael J. Cyprys - Morgan Stanley, Research Division Michael J.
Asset Management Industry | Financial Services Sector | Mr. Joseph Y. Bae CEO | NYSE Exchange | 48251W104 Cusip |
US Country | 4,834 Employees | - Last Dividend | - Last Split | 15 Jul 2010 IPO Date |
KKR & Co. Inc. stands as a prominent investment firm with a keen focus on private equity and real estate investments. Through its diverse strategies, it engages in a variety of investment activities, including direct investments and fund of funds. The company's investment approach is characterized by a mix of acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature investments, mezzanine financing, distressed and turnaround situations, as well as investments in lower middle market and middle market segments. KKR & Co. Inc. prides itself on its versatility, with interests spanning across numerous industries, making it a comprehensive and dynamic player in the investment space.
The investment offerings of KKR & Co. Inc. are wide-ranging and tailored to meet the intricate needs of various sectors: